Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
969-972
Author(s):
Hideyuki Hyogo and Sho-ichi Yamagishi
Arginine Deprivation as a Targeted Therapy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1049-1057
Author(s):
L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1058-1077
Author(s):
Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic
Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1098-1112
Author(s):
B. Spankuch and K. Strebhardt
Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1143-1150
Author(s):
J. Stankova, A. K. Lawrance and R. Rozen
Multiple Functions of Generic Drugs: Future Perspectives of Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
8
Page:
331-349
Author(s):
Hirak Chakraborty, Pukhrambam Grihanjali Devi, Munna Sarkar and Dipak Dasgupta
Neprilysin and Amyloid Beta Peptide Degradation
Journal:
Current Alzheimer Research
Volume:
5
Page:
225-231
Author(s):
Louis B. Hersh and David W. Rodgers
ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Journal:
Current Neuropharmacology
Volume:
6
Page:
21-38
Author(s):
Basil D. Roufogalis and Sravan Mandadi
Pharmacodynamics of Memantine: An Update
Journal:
Current Neuropharmacology
Volume:
6
Page:
55-78
Author(s):
C. G. Parsons, G. Rammes and W. Danysz
Herbal Compounds and Toxins Modulating TRP Channels
Journal:
Current Neuropharmacology
Volume:
6
Page:
79-96
Author(s):
Rudi Vennekens, Joris Vriens and Bernd Nilius